GSA CAPITAL PARTNERS LLP - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,070
+22.4%
162,699
+35.5%
0.18%
+4.7%
Q2 2023$1,691
+7.1%
120,095
+17.5%
0.17%
+8.3%
Q1 2023$1,579
+41.1%
102,231
+49.7%
0.16%
+12.2%
Q4 2022$1,119
-99.6%
68,289
+379.3%
0.14%
+297.1%
Q3 2022$264,000
-19.5%
14,247
-42.8%
0.04%
-28.6%
Q2 2022$328,000
+89.6%
24,923
+33.2%
0.05%
+113.0%
Q1 2022$173,000
+15.3%
18,713
+21.6%
0.02%
+21.1%
Q4 2021$150,000
-92.7%
15,388
-74.6%
0.02%
-91.0%
Q3 2021$2,057,000
+637.3%
60,550
+1138.2%
0.21%
+356.5%
Q4 2020$279,000
-29.0%
4,890
-48.8%
0.05%
-53.5%
Q1 2020$393,0009,5480.10%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q2 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$69,030,00015.95%
SV Health Investors, LLC 449,951$25,679,00012.37%
Sunesis Advisors, LLC 96,299$5,496,0004.45%
Redmile Group, LLC 4,437,968$253,275,0003.07%
Consonance Capital Management LP 484,671$27,660,0002.58%
SECTORAL ASSET MANAGEMENT INC 488,842$27,898,0001.97%
Opaleye Management Inc. 222,000$12,670,0001.66%
Eversept Partners, LP 246,240$14,052,9171.65%
SILVERARC CAPITAL MANAGEMENT, LLC 38,620$2,204,0001.28%
Avoro Capital Advisors LLC 1,300,000$74,191,0001.28%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders